International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk?

The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair‐skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied th...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of cancer Vol. 132; no. 2; pp. 385 - 400
Main Authors:	Erdmann, Friederike, Lortet‐Tieulent, Joannie, Schüz, Joachim, Zeeb, Hajo, Greinert, Rüdiger, Breitbart, Eckhard W., Bray, Freddie
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.01.2013 Wiley-Blackwell Wiley Subscription Services, Inc
Subjects:	Adult Age Aged Biological and medical sciences birth cohorts Cancer Dermatology Female global Global Health - history Global Health - trends History, 20th Century History, 21st Century Humans Incidence Male malignant melanoma Medical sciences Melanoma Melanoma - epidemiology Melanoma - history Middle Aged Risk Risk factors Skin Neoplasms - epidemiology Skin Neoplasms - history Sunscreen time trends Tropical medicine Tumors Tumors of the skin and soft tissue. Premalignant lesions New Zealand Canada United States Europe America Australia North America Oceania USA Norway Israel PSE, Australia Human time trends Skin disease birth cohorts global Malignant tumor Epidemiology Time variation Skin cancer Incidence Cancerology Risk factor Malignant melanoma Birth cohort Public health Cancer
ISSN:	0020-7136, 1097-0215, 1097-0215
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair‐skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age‐ and cohort‐specific variations. We analyzed the incidence data from 39 population‐based cancer registries, examining all‐ages and age‐truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age‐period‐cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25–44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period‐related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.
AbstractList	The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries. The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries. [PUBLICATION ABSTRACT] The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair‐skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age‐ and cohort‐specific variations. We analyzed the incidence data from 39 population‐based cancer registries, examining all‐ages and age‐truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age‐period‐cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25–44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period‐related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.
Author	Lortet‐Tieulent, Joannie Greinert, Rüdiger Breitbart, Eckhard W. Erdmann, Friederike Bray, Freddie Schüz, Joachim Zeeb, Hajo
Author_xml	– sequence: 1 givenname: Friederike surname: Erdmann fullname: Erdmann, Friederike email: erdmannf@students.iarc.fr – sequence: 2 givenname: Joannie surname: Lortet‐Tieulent fullname: Lortet‐Tieulent, Joannie – sequence: 3 givenname: Joachim surname: Schüz fullname: Schüz, Joachim – sequence: 4 givenname: Hajo surname: Zeeb fullname: Zeeb, Hajo – sequence: 5 givenname: Rüdiger surname: Greinert fullname: Greinert, Rüdiger – sequence: 6 givenname: Eckhard W. surname: Breitbart fullname: Breitbart, Eckhard W. – sequence: 7 givenname: Freddie surname: Bray fullname: Bray, Freddie
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26904001$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22532371$$D View this record in MEDLINE/PubMed
BookMark	eNqFkt9qFDEUxoNU7LZ64QtIQAS9mPbkz2QmVyJL1ZWCN3od0szZ3awzSU1mKXvXd7BP2Ccx-6cIRfEmJ5Df98H58p2QoxADEvKSwRkD4Od-5c54o5h6QiYMdFMBZ_URmZQ3qBom1DE5yXkFwFgN8hk55rwWXDRsQjazMGIKdvQx2J6OCUOXqQ90XGIZzncYHNI4p4Pt_SLYMNIBexviYCnTtbi__cUB2vvbO5uQJnRYiAUGTDvPTO1Il36xxERjon28KZfk84_3z8nTue0zvjjMU_L948W36efq8uun2fTDZeWkAFXZljuuJTrVChCSK4WaScG6ru5a2fGWS9vAXNfagYYrK20LHbTCqU7rWnXilLzd-16n-HONeTSDzw77sgPGdTZMSiEa3pTzvyhrlRZMaijo60foKq5Ljv3WUAjGuWq31KsDtb4asDPXyQ82bcxD_gV4cwBsdrafJ1siz384pUGWbyvc-Z5zKeaccG6cH3cBj8n63jAw2yaY0gSza0JRvHukeDD9G3twv_E9bv4NmtmX6V7xGxiYwEs
CODEN	IJCNAW
CitedBy_id	crossref_primary_10_1016_j_adengl_2019_05_017 crossref_primary_10_1080_2162402X_2017_1326440 crossref_primary_10_1590_s2175_97902025e24510 crossref_primary_10_3390_ijms232415650 crossref_primary_10_1007_s13555_021_00583_z crossref_primary_10_1016_j_ejca_2023_04_016 crossref_primary_10_1245_s10434_016_5263_7 crossref_primary_10_1038_nrdp_2015_3 crossref_primary_10_1016_j_canep_2021_101947 crossref_primary_10_1038_s41598_018_33763_7 crossref_primary_10_1097_CMR_0000000000000479 crossref_primary_10_1016_j_jaad_2016_09_029 crossref_primary_10_3390_ijms23031119 crossref_primary_10_1111_pcmr_12712 crossref_primary_10_1007_s13555_016_0165_y crossref_primary_10_3390_cells9010026 crossref_primary_10_1007_s10552_013_0227_8 crossref_primary_10_1517_14712598_2014_902928 crossref_primary_10_21101_cejph_a4975 crossref_primary_10_1007_s11051_013_1835_7 crossref_primary_10_3390_healthcare11131907 crossref_primary_10_1155_2016_6829283 crossref_primary_10_1016_j_jdermsci_2016_09_003 crossref_primary_10_1136_bmjopen_2018_028092 crossref_primary_10_1097_CMR_0000000000000385 crossref_primary_10_1371_journal_pone_0109339 crossref_primary_10_1093_jscr_rjz324 crossref_primary_10_3390_cancers13184722 crossref_primary_10_1007_s11845_017_1574_3 crossref_primary_10_1159_000364887 crossref_primary_10_1016_j_ejca_2017_07_052 crossref_primary_10_1111_bjd_15170 crossref_primary_10_1111_ddg_12891 crossref_primary_10_1111_ijd_13839 crossref_primary_10_1186_s40644_017_0122_8 crossref_primary_10_1159_000510582 crossref_primary_10_1002_ijc_30407 crossref_primary_10_1136_annrheumdis_2016_209285 crossref_primary_10_1016_j_ijwd_2020_07_003 crossref_primary_10_1080_07391102_2023_2240409 crossref_primary_10_1186_0717_6287_48_1 crossref_primary_10_1038_515S114a crossref_primary_10_1016_j_canep_2023_102321 crossref_primary_10_1016_j_ejca_2015_09_008 crossref_primary_10_1158_0008_5472_CAN_15_3211 crossref_primary_10_1016_j_ejca_2015_11_019 crossref_primary_10_1001_jamadermatol_2022_0160 crossref_primary_10_1186_s12199_020_00875_4 crossref_primary_10_1001_jamadermatol_2022_0162 crossref_primary_10_1002_1878_0261_12669 crossref_primary_10_3389_fimmu_2017_01617 crossref_primary_10_14326_abe_5_111 crossref_primary_10_3390_environments7020010 crossref_primary_10_1002_ijc_31984 crossref_primary_10_1186_s12885_019_6139_6 crossref_primary_10_1016_j_ejca_2019_04_033 crossref_primary_10_1097_CMR_0000000000001017 crossref_primary_10_1093_jnci_djaa088 crossref_primary_10_1002_ijc_30659 crossref_primary_10_1016_j_mehy_2016_10_011 crossref_primary_10_1007_s10198_015_0757_y crossref_primary_10_1111_bjd_17277 crossref_primary_10_1111_jdv_12236 crossref_primary_10_3892_or_2015_4439 crossref_primary_10_3390_ijerph191912309 crossref_primary_10_1186_s12885_021_08879_1 crossref_primary_10_11648_j_jher_20251103_11 crossref_primary_10_1007_s11912_012_0256_6 crossref_primary_10_1093_ced_llae516 crossref_primary_10_1007_s12094_013_1140_z crossref_primary_10_1177_03008916231179251 crossref_primary_10_1200_GO_22_00338 crossref_primary_10_1155_2016_2908917 crossref_primary_10_1016_j_ejrad_2017_07_017 crossref_primary_10_3390_ijerph18041615 crossref_primary_10_1016_j_jid_2017_06_024 crossref_primary_10_12688_f1000research_10491_1 crossref_primary_10_1111_bjd_16079 crossref_primary_10_1007_s00432_025_06176_z crossref_primary_10_1016_j_ijpharm_2017_07_078 crossref_primary_10_3390_cancers13133302 crossref_primary_10_3390_ijerph15091793 crossref_primary_10_1007_s15012_012_0199_5 crossref_primary_10_1016_j_jid_2018_07_009 crossref_primary_10_1111_jdv_15614 crossref_primary_10_1007_s11764_020_00971_y crossref_primary_10_1002_ijc_31527 crossref_primary_10_12688_f1000research_10491_2 crossref_primary_10_3390_cancers13112838 crossref_primary_10_1002_jcb_25656 crossref_primary_10_1371_journal_pone_0285806 crossref_primary_10_1016_j_phymed_2025_156810 crossref_primary_10_1016_j_det_2018_12_005 crossref_primary_10_1039_c8pp90060d crossref_primary_10_1186_s40463_015_0107_1 crossref_primary_10_2217_cer_2016_0023 crossref_primary_10_1038_s41572_025_00603_8 crossref_primary_10_7717_peerj_6189 crossref_primary_10_1007_s00210_025_04431_1 crossref_primary_10_1016_j_mayocp_2022_10_029 crossref_primary_10_1186_s12885_022_09781_0 crossref_primary_10_3390_ijms21103737 crossref_primary_10_1007_s00238_016_1228_0 crossref_primary_10_1080_2000656X_2018_1493388 crossref_primary_10_1364_AO_59_000180 crossref_primary_10_1007_s11060_015_1977_9 crossref_primary_10_1097_CMR_0000000000000880 crossref_primary_10_1039_c4pp90033b crossref_primary_10_3892_etm_2018_6413 crossref_primary_10_1111_bjd_19015 crossref_primary_10_1016_j_canep_2014_10_010 crossref_primary_10_1097_CEJ_0000000000000382 crossref_primary_10_1007_s13555_022_00884_x crossref_primary_10_1007_s00105_025_05570_5 crossref_primary_10_1186_s12889_021_10424_5 crossref_primary_10_1016_j_ijbiomac_2023_124058 crossref_primary_10_3390_bios15050297 crossref_primary_10_1007_s11886_019_1183_z crossref_primary_10_3322_caac_21577 crossref_primary_10_3945_jn_114_209320 crossref_primary_10_1016_j_jid_2016_03_014 crossref_primary_10_1016_j_cbi_2016_08_005 crossref_primary_10_1002_cam4_4334 crossref_primary_10_1001_jamadermatol_2024_3514 crossref_primary_10_1111_1346_8138_15904 crossref_primary_10_1007_s00403_020_02163_1 crossref_primary_10_2147_CMAR_S423970 crossref_primary_10_1016_j_ad_2025_04_002 crossref_primary_10_1111_bjd_12995 crossref_primary_10_3390_ijerph17217919 crossref_primary_10_1002_ijc_28031 crossref_primary_10_1016_j_advms_2019_02_002 crossref_primary_10_1016_j_jaad_2013_11_050 crossref_primary_10_2196_10676 crossref_primary_10_2196_35930 crossref_primary_10_3389_ijph_2022_1604716 crossref_primary_10_4103_ijd_IJD_543_19 crossref_primary_10_1039_c3pp50154j crossref_primary_10_3390_dermatopathology9040043 crossref_primary_10_1016_j_intimp_2018_12_037 crossref_primary_10_3389_fimmu_2017_01594 crossref_primary_10_1007_s00238_016_1234_2 crossref_primary_10_1371_journal_pone_0223854 crossref_primary_10_1097_CMR_0000000000000898 crossref_primary_10_1177_1403494813479216 crossref_primary_10_1038_nrc_2017_43 crossref_primary_10_1111_bjd_19010 crossref_primary_10_1136_jmedgenet_2020_107251 crossref_primary_10_1097_CEJ_0000000000000489 crossref_primary_10_4161_onci_23288 crossref_primary_10_1016_j_rcl_2013_06_004 crossref_primary_10_1016_j_anr_2015_04_006 crossref_primary_10_1371_journal_pone_0131649 crossref_primary_10_1111_bjd_12856 crossref_primary_10_3322_caac_21660 crossref_primary_10_1016_j_ijheh_2015_09_008 crossref_primary_10_2196_13844 crossref_primary_10_1200_GO_20_00426 crossref_primary_10_1038_bjc_2014_522 crossref_primary_10_1016_j_ejca_2013_10_019 crossref_primary_10_5694_mja17_00725 crossref_primary_10_1097_CMR_0000000000000322 crossref_primary_10_1016_j_ejca_2016_02_029 crossref_primary_10_1016_j_ydbio_2018_02_008 crossref_primary_10_1186_s12889_019_7382_0 crossref_primary_10_3390_ijerph192416806 crossref_primary_10_1517_14712598_2016_1141195 crossref_primary_10_1016_j_canep_2018_08_004 crossref_primary_10_1016_j_ejca_2015_01_056 crossref_primary_10_1097_CMR_0000000000000436 crossref_primary_10_1039_c6pp90004f crossref_primary_10_1080_09603123_2019_1572105 crossref_primary_10_2217_fon_2018_0671 crossref_primary_10_3390_ijms22073783 crossref_primary_10_3389_fonc_2020_612459 crossref_primary_10_2174_1570180817666200402124503 crossref_primary_10_1111_jdv_12887 crossref_primary_10_1016_j_jid_2016_01_035 crossref_primary_10_1111_bjd_13403 crossref_primary_10_1016_j_ejca_2021_09_044 crossref_primary_10_3390_jcm10143101 crossref_primary_10_1002_gcc_22528 crossref_primary_10_1017_S0954102014000790 crossref_primary_10_1007_s10269_013_2258_x crossref_primary_10_1002_pmic_201400039 crossref_primary_10_3390_app10238692 crossref_primary_10_1111_bjd_19166 crossref_primary_10_1111_phpp_70013 crossref_primary_10_1016_j_ejca_2019_06_016 crossref_primary_10_3390_cancers15153966 crossref_primary_10_1097_CEJ_0000000000000279 crossref_primary_10_1097_CMR_0000000000000464 crossref_primary_10_1002_jcb_26225 crossref_primary_10_1007_s10654_020_00637_0 crossref_primary_10_3390_ph6040557 crossref_primary_10_1136_bmjopen_2016_014096 crossref_primary_10_1371_journal_pone_0126394 crossref_primary_10_1111_ijd_14334 crossref_primary_10_3390_cancers13153866 crossref_primary_10_1016_j_suronc_2017_08_006 crossref_primary_10_1186_1471_5945_14_4 crossref_primary_10_1016_j_suronc_2020_10_018 crossref_primary_10_1080_2162402X_2016_1191732 crossref_primary_10_1002_ijc_29297 crossref_primary_10_3390_cancers15010020 crossref_primary_10_1097_CMR_0000000000000570 crossref_primary_10_1007_s12094_019_02169_w crossref_primary_10_1371_journal_pone_0206087 crossref_primary_10_3109_0284186X_2016_1144934 crossref_primary_10_1016_j_critrevonc_2017_05_001 crossref_primary_10_1245_s10434_015_4589_x crossref_primary_10_1038_bjc_2014_169 crossref_primary_10_1136_bmjopen_2018_022094 crossref_primary_10_1158_1940_6207_CAPR_14_0018 crossref_primary_10_1093_ije_dyw226 crossref_primary_10_1111_bjd_12460 crossref_primary_10_1016_j_biopha_2016_04_051 crossref_primary_10_1002_ijc_31141 crossref_primary_10_1111_bjd_13434 crossref_primary_10_1016_j_ejca_2016_01_011 crossref_primary_10_1117_1_JBO_29_S1_S11518 crossref_primary_10_1007_s12254_019_0512_7 crossref_primary_10_1111_jdv_15022 crossref_primary_10_1111_bjd_21051 crossref_primary_10_1111_ijd_15438 crossref_primary_10_1007_s10552_016_0777_7 crossref_primary_10_1016_j_mednuc_2015_03_190 crossref_primary_10_1038_s41598_024_65065_6 crossref_primary_10_1016_j_soncn_2013_06_002 crossref_primary_10_3389_ijph_2024_1607604 crossref_primary_10_1111_dth_14715 crossref_primary_10_3892_ol_2018_8913 crossref_primary_10_1002_ctm2_451 crossref_primary_10_1016_j_ejca_2015_07_039 crossref_primary_10_1111_phpp_12287 crossref_primary_10_3389_fonc_2018_00675 crossref_primary_10_1007_s12257_022_0299_y crossref_primary_10_1038_s41598_019_54438_x crossref_primary_10_1111_jdv_17437 crossref_primary_10_1016_j_ad_2024_10_062 crossref_primary_10_2340_actadv_v104_26110 crossref_primary_10_1016_j_mayocp_2017_01_017 crossref_primary_10_1093_jnci_djy023 crossref_primary_10_1016_j_ad_2019_05_006 crossref_primary_10_1111_jdv_18635 crossref_primary_10_1007_s12094_018_1900_x crossref_primary_10_3390_ijerph16122067 crossref_primary_10_1080_01635581_2015_1053499 crossref_primary_10_1186_s40164_019_0138_9 crossref_primary_10_3390_cancers16061167 crossref_primary_10_2217_imt_2015_0024 crossref_primary_10_2217_fon_15_297 crossref_primary_10_1016_j_canep_2014_12_014 crossref_primary_10_1111_jdv_14280 crossref_primary_10_3389_fpubh_2016_00078 crossref_primary_10_1016_j_ejso_2016_07_001 crossref_primary_10_3390_ijerph19159590 crossref_primary_10_3390_ijerph192316118 crossref_primary_10_1111_ajd_13974 crossref_primary_10_3389_fonc_2021_745550 crossref_primary_10_7717_peerj_11473 crossref_primary_10_1016_j_jval_2016_05_013 crossref_primary_10_1093_ije_dyt277 crossref_primary_10_1186_s13045_016_0369_8 crossref_primary_10_1016_j_ejca_2017_12_024 crossref_primary_10_1016_j_ejca_2018_06_030 crossref_primary_10_1634_theoncologist_2019_0148 crossref_primary_10_1016_j_scitotenv_2016_09_102 crossref_primary_10_1016_S0140_6736_13_60802_8 crossref_primary_10_1097_CMR_0000000000000609 crossref_primary_10_3389_fmed_2018_00152 crossref_primary_10_3897_pharmacia_71_e141361 crossref_primary_10_3390_molecules24132483 crossref_primary_10_1002_ijc_33259 crossref_primary_10_1002_wnan_1997 crossref_primary_10_1016_j_jid_2018_12_006 crossref_primary_10_1111_bjd_13483 crossref_primary_10_1016_j_gene_2020_144964 crossref_primary_10_1016_j_ejca_2023_112954 crossref_primary_10_1111_jdv_20524 crossref_primary_10_1016_j_compbiomed_2021_104916 crossref_primary_10_1186_s12885_022_10253_8 crossref_primary_10_1016_j_ijmedinf_2018_08_004 crossref_primary_10_1200_JCO_2016_67_5934 crossref_primary_10_1111_phpp_12450 crossref_primary_10_1155_2019_5719483 crossref_primary_10_1111_bjhp_12650 crossref_primary_10_2217_mmt_2016_0022 crossref_primary_10_1111_bjd_13213 crossref_primary_10_3389_fimmu_2015_00649 crossref_primary_10_1002_ptr_5696 crossref_primary_10_1007_s10389_020_01232_z crossref_primary_10_1016_j_micres_2021_126768 crossref_primary_10_1016_j_canep_2015_12_006 crossref_primary_10_1111_bjd_15759 crossref_primary_10_1080_15384101_2016_1175258 crossref_primary_10_1097_jnr_0000000000000326 crossref_primary_10_1111_php_12252 crossref_primary_10_1016_j_jaad_2017_06_152 crossref_primary_10_1111_ajd_12433 crossref_primary_10_3390_ijerph14020176 crossref_primary_10_1007_s00394_018_1613_5 crossref_primary_10_1111_bjd_12492 crossref_primary_10_1016_j_jdin_2024_04_010 crossref_primary_10_1111_1753_6405_12272 crossref_primary_10_1186_s12885_016_2963_0 crossref_primary_10_1007_s41669_019_00193_8 crossref_primary_10_1097_PAT_0000000000000314 crossref_primary_10_1111_jdv_14104 crossref_primary_10_1007_s00520_016_3378_9 crossref_primary_10_1016_j_amjsurg_2015_09_022 crossref_primary_10_3390_ijms17020160 crossref_primary_10_1111_ddg_150_12891 crossref_primary_10_1007_s13187_018_1369_x crossref_primary_10_1111_bjd_15450 crossref_primary_10_1016_j_jaad_2024_09_035 crossref_primary_10_1007_s10354_013_0207_3 crossref_primary_10_3390_nu13114018 crossref_primary_10_1177_2158244014559023 crossref_primary_10_1038_jes_2014_6 crossref_primary_10_5694_mja12_11499 crossref_primary_10_1016_j_ypmed_2016_05_016 crossref_primary_10_1155_2020_8836493 crossref_primary_10_1016_j_ijosm_2016_01_001 crossref_primary_10_1590_0100_6991e_20181715 crossref_primary_10_14326_abe_9_225 crossref_primary_10_3389_pore_2024_1611809 crossref_primary_10_1016_j_jaad_2020_03_076 crossref_primary_10_3390_healthcare9020229 crossref_primary_10_1111_jocd_15528 crossref_primary_10_2217_mmt_14_15 crossref_primary_10_1007_s41669_020_00206_x crossref_primary_10_1016_j_actbio_2024_11_018 crossref_primary_10_1111_nhs_12396 crossref_primary_10_1080_17460441_2020_1746265 crossref_primary_10_1016_S0140_6736_13_62224_2 crossref_primary_10_1111_jdv_16983 crossref_primary_10_1016_j_sste_2016_05_005 crossref_primary_10_1186_s40880_017_0179_6 crossref_primary_10_1007_s00520_021_06760_2 crossref_primary_10_1016_j_pharmthera_2021_107829 crossref_primary_10_3390_cancers12030767 crossref_primary_10_12688_f1000research_6962_1 crossref_primary_10_1002_ijc_28956 crossref_primary_10_1088_1361_6498_ad7ff5 crossref_primary_10_1111_dth_15067 crossref_primary_10_1007_s12094_018_1987_0 crossref_primary_10_2217_mmt_14_31 crossref_primary_10_1080_01443615_2019_1588236 crossref_primary_10_1177_0272989X14543106 crossref_primary_10_1002_cnm_2953 crossref_primary_10_1016_j_critrevonc_2017_12_003 crossref_primary_10_2196_13376 crossref_primary_10_1186_s12911_025_03074_9 crossref_primary_10_1007_s13187_020_01732_2 crossref_primary_10_1016_j_phrs_2018_08_019 crossref_primary_10_1002_jso_24013 crossref_primary_10_1111_phpp_12425 crossref_primary_10_3390_genes10110915 crossref_primary_10_1111_jdv_13110 crossref_primary_10_1007_s00403_023_02730_2 crossref_primary_10_1158_1940_6207_CAPR_21_0244 crossref_primary_10_1109_JMEMS_2018_2802321 crossref_primary_10_3389_fpubh_2020_569857 crossref_primary_10_1007_s00403_023_02547_z crossref_primary_10_1186_s12885_020_07485_x crossref_primary_10_1016_j_jaad_2014_03_029 crossref_primary_10_1016_j_jcms_2018_04_011 crossref_primary_10_1155_2018_7289896 crossref_primary_10_1177_1010428317694315 crossref_primary_10_1002_dc_23637 crossref_primary_10_1111_jdv_14376 crossref_primary_10_1097_MD_0000000000004396 crossref_primary_10_1111_jdv_14138 crossref_primary_10_1080_0284186X_2018_1449251 crossref_primary_10_1007_s13193_024_01920_2 crossref_primary_10_1038_cgt_2014_35 crossref_primary_10_1016_j_suc_2014_07_013 crossref_primary_10_3390_cancers13133143 crossref_primary_10_3727_096504017X14920318811749 crossref_primary_10_1111_bjd_18411 crossref_primary_10_2217_mmt_15_25 crossref_primary_10_1016_j_ejca_2020_03_011 crossref_primary_10_1111_phpp_12525 crossref_primary_10_3892_ol_2016_4292 crossref_primary_10_1016_j_canep_2021_101975 crossref_primary_10_1177_1203475418773360 crossref_primary_10_1016_j_rcl_2021_05_007 crossref_primary_10_1097_SAP_0000000000001465 crossref_primary_10_1097_HJH_0000000000002379 crossref_primary_10_1016_j_ejca_2021_04_029 crossref_primary_10_1097_CEJ_0000000000000716 crossref_primary_10_1002_ajim_22741 crossref_primary_10_1007_s11864_014_0282_8 crossref_primary_10_1016_j_mayocp_2013_09_014 crossref_primary_10_1016_j_jpba_2017_10_025 crossref_primary_10_1159_000502129 crossref_primary_10_1111_jan_13221 crossref_primary_10_1111_jdv_15322 crossref_primary_10_1007_s10811_016_0979_0 crossref_primary_10_1111_jdv_15565 crossref_primary_10_1007_s11845_016_1531_6 crossref_primary_10_3390_ijerph17020529 crossref_primary_10_3389_fpubh_2021_596253 crossref_primary_10_3390_ijerph13101011 crossref_primary_10_3390_children9020198 crossref_primary_10_1186_s12885_015_1517_1
Cites_doi	10.1080/028418602753669508 10.1097/00008469-200302000-00007 10.1038/jid.2009.328 10.1093/jjco/hyn012 10.1016/j.ejca.2005.03.034 10.1002/ijc.23495 10.1016/j.bjps.2006.05.008 10.1016/j.clindermatol.2009.06.021 10.1001/archderm.135.12.1451 10.1016/S0959-8049(98)00003-3 10.1097/00008469-200410000-00006 10.1002/ijc.11360 10.1016/j.ejca.2009.03.004 10.3109/02841861003702528 10.1093/ije/25.6.1132 10.1158/1078-0432.CCR-05-2559 10.1177/109019810102800304 10.1177/1536867X1101000405 10.1093/oxfordjournals.aje.a116210 10.1023/A:1008980919928 10.1002/cncr.24481 10.1002/ijc.25996 10.1097/00008469-200110000-00004 10.1038/sj.bjc.6603801 10.1016/j.pbiomolbio.2011.09.011 10.1200/JCO.2006.06.1325 10.1023/A:1008964621225 10.1016/j.clindermatol.2008.09.001 10.1136/bmj.a2249 10.1007/s10552-005-3637-4 10.1093/ije/29.3.416 10.1093/aje/kwq238 10.1016/j.ejca.2004.10.015 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R 10.1093/annonc/mdr128 10.1097/CEJ.0b013e3282b6fe3f 10.1016/j.ejca.2004.06.003 10.1016/S0140-6736(02)09779-9 10.1016/S0190-9622(99)70562-1 10.1016/S1470-2045(09)70213-X 10.1038/sj.bjc.6603216 10.1038/jid.2010.58 10.1158/1055-9965.EPI-10-0503 10.1016/j.envres.2005.09.007 10.1016/j.ejca.2004.10.016 10.1111/j.1467-842X.2005.tb00211.x 10.1016/j.ejca.2005.04.038
ContentType	Journal Article
Copyright	Copyright © 2012 UICC 2014 INIST-CNRS Copyright © 2012 UICC.
Copyright_xml	– notice: Copyright © 2012 UICC – notice: 2014 INIST-CNRS – notice: Copyright © 2012 UICC.
DBID	AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 7U1 C1K
DOI	10.1002/ijc.27616
DatabaseName	CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management
DatabaseTitleList	MEDLINE - Academic AIDS and Cancer Research Abstracts CrossRef Risk Abstracts MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1097-0215
EndPage	400
ExternalDocumentID	3073996521 22532371 26904001 10_1002_ijc_27616 IJC27616
Genre	article Historical Article Journal Article Feature
GeographicLocations	New Zealand Canada United States Europe America Australia North America Oceania USA Norway Israel PSE, Australia
GeographicLocations_xml	– name: Israel – name: Canada – name: USA – name: PSE, Australia – name: New Zealand – name: Europe – name: Norway
GroupedDBID	--- -~X .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGXDD AGYGG AHBTC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAYXX CITATION O8X .55 .GJ 31~ 3O- 53G 8WZ A6W AAHHS AANHP ABEFU ABEML ACBWZ ACCFJ ACRPL ACSCC ACYXJ ADNMO ADZOD AEEZP AEQDE AGHNM AHEFC AI. AIWBW AJBDE ASPBG AVWKF AZFZN BDRZF EX3 FEDTE GLUZI HF~ HVGLF IQODW M6P PALCI SAMSI VH1 WOW X7M Y6R ZGI ZXP CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 7U1 C1K
ID	FETCH-LOGICAL-c4306-a82c294ec683034266e91431dd5d84d2824a70f959c090ba4a80d083c6d9956d3
IEDL.DBID	DRFUL
ISSN	0020-7136 1097-0215
IngestDate	Tue Oct 07 09:33:23 EDT 2025 Wed Oct 01 14:13:24 EDT 2025 Sat Nov 29 14:50:52 EST 2025 Thu Apr 03 07:06:56 EDT 2025 Wed Apr 02 07:23:34 EDT 2025 Tue Nov 18 22:32:58 EST 2025 Sat Nov 29 03:45:26 EST 2025 Wed Aug 20 07:26:55 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	Human time trends Skin disease birth cohorts global Malignant tumor Epidemiology Time variation Skin cancer Incidence Cancerology Risk factor Malignant melanoma Birth cohort Public health Cancer
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 Copyright © 2012 UICC.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4306-a82c294ec683034266e91431dd5d84d2824a70f959c090ba4a80d083c6d9956d3
Notes	Tel.: +33‐(0)4‐72‐73‐84‐63, Fax: +33‐(0)4‐72‐73‐83‐20 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2
PMID	22532371
PQID	1433122680
PQPubID	105430
PageCount	16
ParticipantIDs	proquest_miscellaneous_1443372743 proquest_miscellaneous_1186931490 proquest_journals_1433122680 pubmed_primary_22532371 pascalfrancis_primary_26904001 crossref_citationtrail_10_1002_ijc_27616 crossref_primary_10_1002_ijc_27616 wiley_primary_10_1002_ijc_27616_IJC27616
PublicationCentury	2000
PublicationDate	15 January 2013
PublicationDateYYYYMMDD	2013-01-15
PublicationDate_xml	– month: 01 year: 2013 text: 15 January 2013 day: 15
PublicationDecade	2010
PublicationPlace	Hoboken
PublicationPlace_xml	– name: Hoboken – name: Hoboken, NJ – name: United States
PublicationTitle	International journal of cancer
PublicationTitleAlternate	Int J Cancer
PublicationYear	2013
Publisher	Wiley Subscription Services, Inc., A Wiley Company Wiley-Blackwell Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Blackwell – name: Wiley Subscription Services, Inc
References	2009; 45 2010; 10 1992; VI 2010; 19 2008; 38 1999; 40 2005; 29 2009; 115 2003; 12 2012; 130 2009; 10 2002; 41 2006; 24 2010; 28 1999; 10 1999; 135 2007; 60 1996; 25 2010; 2 2001; 12 2012; 23 1998; 10 2001; 10 2000; 29 2004; 40 2006; 95 2006; 12 2010 in press 2006; 17 2008; 17 2005; 41 2001; 28 2007; 96 2008; 123 2008; 121 2009; 27 2010; 49 1997; 73 2003; 107 2011; 107 2002; 360 1992; 135 2004; 13 2010; 130 2008; 337 2010; 172 2006; 101 1998; 34 e_1_2_6_51_2 Ferlay J (e_1_2_6_2_2) 2010 e_1_2_6_30_2 Boyle P (e_1_2_6_40_2) e_1_2_6_19_2 e_1_2_6_13_2 e_1_2_6_34_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_55_2 e_1_2_6_15_2 e_1_2_6_36_2 e_1_2_6_57_2 Day NE (e_1_2_6_39_2) 1992 e_1_2_6_41_2 Ferlay J (e_1_2_6_38_2) e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_3_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_47_2 e_1_2_6_22_2 e_1_2_6_49_2 e_1_2_6_28_2 e_1_2_6_43_2 e_1_2_6_26_2 e_1_2_6_45_2 e_1_2_6_50_2 e_1_2_6_52_2 Gaudette LA (e_1_2_6_53_2) 1998; 10 e_1_2_6_31_2 e_1_2_6_18_2 e_1_2_6_12_2 e_1_2_6_35_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_16_2 e_1_2_6_54_2 e_1_2_6_14_2 e_1_2_6_37_2 e_1_2_6_56_2 e_1_2_6_42_2 Richardson A (e_1_2_6_17_2) 2008; 121 e_1_2_6_8_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_6_2 de Haas E (e_1_2_6_20_2) 2010; 2 e_1_2_6_23_2 e_1_2_6_48_2 e_1_2_6_21_2 e_1_2_6_27_2 e_1_2_6_44_2 e_1_2_6_25_2 e_1_2_6_46_2
References_xml	– volume: 12 start-page: 43 year: 2003 end-page: 58 article-title: Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994 publication-title: Eur J Cancer Prev – volume: 23 start-page: 524 year: 2012 end-page: 30 article-title: Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989 publication-title: Ann Oncol – volume: 73 start-page: 198 year: 1997 end-page: 203 article-title: Melanoma and sun exposure: an overview of published studies publication-title: Int J Cancer – volume: 49 start-page: 665 year: 2010 end-page: 72 article-title: Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006 publication-title: Acta Oncol – volume: 10 start-page: 407 year: 1999 end-page: 16 article-title: Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969–93 publication-title: Cancer Causes Control – volume: 41 start-page: 45 year: 2005 end-page: 60 article-title: Meta‐analysis of risk factors for cutaneous melanoma: II. Sun exposure publication-title: Eur J Cancer – volume: 135 start-page: 1451 year: 1999 end-page: 6 article-title: Striking increase of thin melanomas contrasts with stable incidence of thick melanomas publication-title: Arch Dermatol – volume: 337 start-page: a2249 year: 2008 article-title: Melanoma—Part 1: epidemiology, risk factors, and prevention publication-title: BMJ – volume: 130 start-page: 170 year: 2012 end-page: 8 article-title: Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006 publication-title: Int J Cancer – volume: 29 start-page: 416 year: 2000 end-page: 23 article-title: Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993 publication-title: Int J Epidemiol – volume: 115 start-page: 4176 year: 2009 end-page: 85 article-title: Divergent cancer pathways for early‐onset and late‐onset cutaneous malignant melanoma publication-title: Cancer – volume: 121 start-page: 18 year: 2008 end-page: 26 article-title: The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994–2004 publication-title: N Z Med J – volume: 172 start-page: 762 year: 2010 end-page: 7 article-title: A melanoma epidemic in iceland: possible influence of sunbed use publication-title: Am J Epidemiol – volume: 40 start-page: 35 year: 1999 end-page: 42 article-title: Update on the incidence and mortality from melanoma in the United States publication-title: J Am Acad Dermatol – volume: 40 start-page: 2355 year: 2004 end-page: 66 article-title: Cutaneous malignant melanoma in Europe publication-title: Eur J Cancer – volume: 2 start-page: 112 year: 2010 end-page: 6 article-title: Population education in preventing skin cancer: from childhood to adulthood publication-title: J Drugs Dermatol – volume: 12 start-page: 69 year: 2001 end-page: 82 article-title: Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies publication-title: Cancer Causes Control – volume: 13 start-page: 387 year: 2004 end-page: 95 article-title: Monitoring stage‐specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics publication-title: Eur J Cancer Prev – volume: 10 start-page: 751 year: 2009 end-page: 2 article-title: A review of human carcinogens—part D: radiation publication-title: Lancet Oncol – volume: 360 start-page: 587 year: 2002 end-page: 91 article-title: Incidence of and survival from malignant melanoma in Scotland: an epidemiological study publication-title: Lancet – volume: 101 start-page: 123 year: 2006 end-page: 31 article-title: Population exposure to ultraviolet radiation in Finland 1920–1995: exposure trends and a time‐series analysis of exposure and cutaneous melanoma incidence publication-title: Environ Res – volume: 34 start-page: S3 year: 1998 end-page: 6 article-title: Incidence, risk factors and prevention of melanoma publication-title: Eur J Cancer – volume: 28 start-page: 281 year: 2010 end-page: 6 article-title: Melanoma epidemic: facts and controversies publication-title: Clin Dermatol – volume: VI start-page: 862 year: 1992 end-page: 864 – volume: 135 start-page: 1103 year: 1992 end-page: 13 article-title: Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay publication-title: Am J Epidemiol – year: in press – volume: 24 start-page: 3172 year: 2006 end-page: 7 article-title: Anatomic site, sun exposure, and risk of cutaneous melanoma publication-title: J Clin Oncol – volume: 41 start-page: 2141 year: 2005 end-page: 9 article-title: A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe publication-title: Eur J Cancer – volume: 96 start-page: 1772 year: 2007 end-page: 7 article-title: Melanoma incidence and mortality in Scotland 1979–2003 publication-title: Br J Cancer – volume: 41 start-page: 28 year: 2005 end-page: 44 article-title: Meta‐analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi publication-title: Eur J Cancer – volume: 130 start-page: 793 year: 2010 end-page: 7 article-title: Melanoma thickness trends in the United States, 1988–2006 publication-title: J Invest Dermatol – volume: 17 start-page: 243 year: 2008 end-page: 50 article-title: Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? publication-title: Eur J Cancer Prev – volume: 123 start-page: 861 year: 2008 end-page: 6 article-title: Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003 publication-title: Int J Cancer – volume: 60 start-page: 32 year: 2007 end-page: 40 article-title: Incidence, mortality and survival in cutaneous melanoma publication-title: J Plast Reconstr Aesthet Surg – volume: 107 start-page: 119 year: 2003 end-page: 26 article-title: Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia publication-title: Int J Cancer – volume: 28 start-page: 290 year: 2001 end-page: 305 article-title: Slip! Slop! Slap! and SunSmart,1980–2000: skin cancer control and 20 years of population‐based campaigning publication-title: Health Educ Behav – volume: 10 start-page: 29 year: 1998 end-page: 41 article-title: Changing trends in melanoma incidence and mortality publication-title: Health Rep – volume: 10 start-page: 407 year: 2001 end-page: 15 article-title: Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 publication-title: Eur J Cancer Prev – volume: 38 start-page: 234 year: 2008 end-page: 6 article-title: Comparison of time trends in skin cancer incidence (1973–97) in East Asia, Europe and USA, from cancer incidence in five continents Vol. IV–VIII publication-title: Jpn J Clin Oncol – volume: 27 start-page: 3 year: 2009 end-page: 9 article-title: Melanoma epidemiology and trends publication-title: Clin Dermatol – volume: 95 start-page: 91 year: 2006 end-page: 5 article-title: Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003 publication-title: Br J Cancer – volume: 41 start-page: 138 year: 2002 end-page: 46 article-title: Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976–1994 publication-title: Acta Oncol – year: 2010 – volume: 12 start-page: 2297s year: 2006 end-page: 300s article-title: Progress and prospects on melanoma: the way forward for early detection and reduced mortality publication-title: Clin Cancer Res – volume: 45 start-page: 2360 year: 2009 end-page: 6 article-title: Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland publication-title: Eur J Cancer – volume: 107 start-page: 362 year: 2011 end-page: 6 article-title: Reviews on sun exposure and artificial light and melanoma publication-title: Prog Biophys Mol Biol – volume: 130 start-page: 1807 year: 2010 end-page: 12 article-title: Incidence and trends of cutaneous malignancies in the Netherlands, 1989–2005 publication-title: J Invest Dermatol – volume: 29 start-page: 383 year: 2005 end-page: 6 article-title: Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control publication-title: Aust N Z J Public Health – volume: 41 start-page: 2040 year: 2005 end-page: 59 article-title: Meta‐analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors publication-title: Eur J Cancer – volume: 17 start-page: 21 year: 2006 end-page: 7 article-title: Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002 publication-title: Cancer Causes Control – volume: 10 start-page: 606 year: 2010 end-page: 27 article-title: Age‐period‐cohort modelling publication-title: Stata J – volume: 19 start-page: 2401 year: 2010 end-page: 6 article-title: Rising melanoma incidence rates of the trunk among younger women in the United States publication-title: Cancer Epidemiol, Biomarkers Prev – volume: 25 start-page: 1132 year: 1996 end-page: 8 article-title: Incidence of malignant melanoma of the skin in Norway, 1955–1989: association with solar ultraviolet radiation, income and holidays abroad publication-title: Int J Epidemiol – ident: e_1_2_6_13_2 doi: 10.1080/028418602753669508 – ident: e_1_2_6_48_2 doi: 10.1097/00008469-200302000-00007 – ident: e_1_2_6_49_2 doi: 10.1038/jid.2009.328 – ident: e_1_2_6_42_2 doi: 10.1093/jjco/hyn012 – ident: e_1_2_6_28_2 doi: 10.1016/j.ejca.2005.03.034 – ident: e_1_2_6_52_2 doi: 10.1002/ijc.23495 – ident: e_1_2_6_33_2 doi: 10.1016/j.bjps.2006.05.008 – ident: e_1_2_6_35_2 doi: 10.1016/j.clindermatol.2009.06.021 – ident: e_1_2_6_22_2 doi: 10.1001/archderm.135.12.1451 – volume: 121 start-page: 18 year: 2008 ident: e_1_2_6_17_2 article-title: The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994–2004 publication-title: N Z Med J – ident: e_1_2_6_54_2 doi: 10.1016/S0959-8049(98)00003-3 – ident: e_1_2_6_57_2 doi: 10.1097/00008469-200410000-00006 – ident: e_1_2_6_4_2 doi: 10.1002/ijc.11360 – ident: e_1_2_6_9_2 doi: 10.1016/j.ejca.2009.03.004 – volume-title: GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC cancerbase no. 10 year: 2010 ident: e_1_2_6_2_2 – ident: e_1_2_6_3_2 doi: 10.3109/02841861003702528 – ident: e_1_2_6_18_2 doi: 10.1093/ije/25.6.1132 – ident: e_1_2_6_37_2 doi: 10.1158/1078-0432.CCR-05-2559 – ident: e_1_2_6_55_2 doi: 10.1177/109019810102800304 – ident: e_1_2_6_41_2 doi: 10.1177/1536867X1101000405 – ident: e_1_2_6_25_2 doi: 10.1093/oxfordjournals.aje.a116210 – ident: e_1_2_6_24_2 doi: 10.1023/A:1008980919928 – ident: e_1_2_6_32_2 doi: 10.1002/cncr.24481 – ident: e_1_2_6_44_2 doi: 10.1002/ijc.25996 – ident: e_1_2_6_12_2 doi: 10.1097/00008469-200110000-00004 – ident: e_1_2_6_21_2 doi: 10.1038/sj.bjc.6603801 – ident: e_1_2_6_29_2 doi: 10.1016/j.pbiomolbio.2011.09.011 – ident: e_1_2_6_31_2 doi: 10.1200/JCO.2006.06.1325 – ident: e_1_2_6_15_2 doi: 10.1023/A:1008964621225 – start-page: 862 volume-title: Cancer incidence in Five continents year: 1992 ident: e_1_2_6_39_2 – ident: e_1_2_6_5_2 doi: 10.1016/j.clindermatol.2008.09.001 – ident: e_1_2_6_23_2 doi: 10.1136/bmj.a2249 – ident: e_1_2_6_6_2 doi: 10.1007/s10552-005-3637-4 – ident: e_1_2_6_50_2 – ident: e_1_2_6_7_2 doi: 10.1093/ije/29.3.416 – ident: e_1_2_6_43_2 doi: 10.1093/aje/kwq238 – ident: e_1_2_6_26_2 doi: 10.1016/j.ejca.2004.10.015 – ident: e_1_2_6_30_2 doi: 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R – ident: e_1_2_6_34_2 doi: 10.1093/annonc/mdr128 – volume-title: Cancer incidence in five continents, volumes I–IX: IARC CancerBase No. 9 ident: e_1_2_6_38_2 – ident: e_1_2_6_16_2 doi: 10.1097/CEJ.0b013e3282b6fe3f – ident: e_1_2_6_19_2 doi: 10.1016/j.ejca.2004.06.003 – ident: e_1_2_6_10_2 doi: 10.1016/S0140-6736(02)09779-9 – ident: e_1_2_6_51_2 – volume: 2 start-page: 112 year: 2010 ident: e_1_2_6_20_2 article-title: Population education in preventing skin cancer: from childhood to adulthood publication-title: J Drugs Dermatol – ident: e_1_2_6_14_2 doi: 10.1016/S0190-9622(99)70562-1 – ident: e_1_2_6_47_2 doi: 10.1016/S1470-2045(09)70213-X – ident: e_1_2_6_11_2 doi: 10.1038/sj.bjc.6603216 – ident: e_1_2_6_8_2 doi: 10.1038/jid.2010.58 – volume-title: Cancer registration: principles and methods. IARC Scientific Publication no. 95 ident: e_1_2_6_40_2 – ident: e_1_2_6_56_2 doi: 10.1158/1055-9965.EPI-10-0503 – ident: e_1_2_6_45_2 doi: 10.1016/j.envres.2005.09.007 – ident: e_1_2_6_27_2 doi: 10.1016/j.ejca.2004.10.016 – volume: 10 start-page: 29 year: 1998 ident: e_1_2_6_53_2 article-title: Changing trends in melanoma incidence and mortality publication-title: Health Rep – ident: e_1_2_6_36_2 doi: 10.1111/j.1467-842X.2005.tb00211.x – ident: e_1_2_6_46_2 doi: 10.1016/j.ejca.2005.04.038
SSID	ssj0011504
Score	2.584924
Snippet	The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair‐skinned populations. This increase is... The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is...
SourceID	proquest pubmed pascalfrancis crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	385
SubjectTerms	Adult Age Aged Biological and medical sciences birth cohorts Cancer Dermatology Female global Global Health - history Global Health - trends History, 20th Century History, 21st Century Humans Incidence Male malignant melanoma Medical sciences Melanoma Melanoma - epidemiology Melanoma - history Middle Aged Risk Risk factors Skin Neoplasms - epidemiology Skin Neoplasms - history Sunscreen time trends Tropical medicine Tumors Tumors of the skin and soft tissue. Premalignant lesions
Title	International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk?
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.27616 https://www.ncbi.nlm.nih.gov/pubmed/22532371 https://www.proquest.com/docview/1433122680 https://www.proquest.com/docview/1186931490 https://www.proquest.com/docview/1443372743
Volume	132
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1097-0215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011504 issn: 0020-7136 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1da9swFL206RiDsXZfnbcuaGMPfXHryJIssYdR2oZ2bGWMFfJmFEnuUhK7JOlgb_0P2y_sL9mV7LgEujHoW8A3jiLdK50jXZ0L8K7gGDNC2phlRocrObEWGUOqIlJdGMaNMaHYRHZyIgcD9WUF3i_uwtT6EO2Gm4-MMF_7ANfD2e6NaOjo3OxQJOFiFdYo-i3vwNrB1_7pp_YQAbFOI8KcxMjFxEJYKKG77ZeXlqOHF3qGPVPUJS1uw5zLEDasQf31O7V-Ax410JPs1b7yGFZc-QTuf24O15_Cz6XdQTIP2bJkVBLEiMRvyYfyo6QqyATB-5nPoCETN9ZlNdHEn5NdX_3yeQ7XV7_11BGcSnFBI2dB1zp4N9Fz8j3klZBqSsa-Phvxqe0fnsFp__Db_lHcVGaIDUOOEWtJDVXMGSFTryEohFMIvHrWciuZRRrHdJYUiiuTqGSomZaJRbBnhPU3aW36HDplVboXQLhiSipjHBJBpgsk6whAhsoilNDCGR7B9mKActPIlvvqGeO8FlymOXZlHroygret6UWt1XGbUXdplFtLij-NE1ovgq3FsOdNPM-QIKEXI1KVSQRv2scYif54RZeuukQbX90rRcb5LxuGL0LIyNIINmuXumkA5SlNM2zAdvCcv_-H_Pjjfvjw8v9NX8EDGip59OIe34LOfHrpXsM982M-mk27sJoNZLcJoD__qRxl
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9swED66dqyDsp_d5rXrbmMPffHqyLJswaCMbqHd0jBGC30zqiR3GYldknSwt_4P7V_Yv6Qn2XEJdGOwt4AvjiLdSd8nnb4DeFckFDMiMyFPtfJXckIlUk5URcSq0DzRWvtiE2m_nx0dyW8L8GF2F6bWh2g33Fxk-PnaBbjbkN66UQ0d_NTvGbFwcQeWOLkR-ffSp-_dw157ikBgp1FhjkIiY2KmLBSxrfbLc-vRyqmaUNcUdU2L20DnPIb1i1D34f81_xE8aMAnfqy95TEs2PIJ3Ntvjtefwu-5_UGc-nxZHJRIKBHdprwvQIpVgSOC7ycuhwZHdqjKaqTQnZRdnV-4TIer80s1tkiTKS1peOKVrb1_o5riD59ZgtUYh65CG7rk9u1VOOx-PtjZDZvaDKHmxDJClTHNJLdaZLFTERTCSoJeHWMSk3FDRI6rNCpkInUko2PFVRYZgntaGHeX1sTPYLGsSvsCMJFcZlJrS1SQq4LoOkGQY2kITChhdRLA5myEct0Il7v6GcO8llxmOXVl7rsygLet6Wmt1nGb0cbcMLeWjH6aprROAOuzcc-biJ4QRSI_JqyaRQG8aR9TLLoDFlXa6oxsXH2vmDjn32w4vYhAI48DeF771E0DWBKzOKUGbHrX-fN_yPe-7PgPL__d9DUs7x7s9_LeXv_rGtxnvq5HJ-wk67A4HZ_ZV3BX_5oOJuONJo6uAUkrH20
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9swED66dJRB2e-13rruNvbQF7eOLMsWFMZoF9atC2Ws0DejSnKXktghSQd76_-w_YX9S3qSHZdANwZ7C_jiKNKd9H3S6T6At0VCMSMyE_JUK38lJ1Qi5URVRKwKzROttRebSPv97OREHi3B7vwuTF0fot1wc5Hh52sX4HZsip2bqqGDc73NiIWLO7DMnYhMB5b3v_aOD9tTBAI7TRXmKCQyJuaVhSK20355YT1aHaspdU1Ra1rcBjoXMaxfhHoP_q_5D-F-Az7xfe0tj2DJlo9h5UtzvP4Efi7sD-LM58vioERCieg25b0AKVYFjgi-n7kcGhzZoSqrkUJ3UnZ1-ctlOlxd_lYTizSZ0pKGZ76ytfdvVDP87jNLsJrg0Cm0oUtuf_cUjnsfvu19DBtthlBzYhmhyphmklststhVERTCSoJeXWMSk3FDRI6rNCpkInUko1PFVRYZgntaGHeX1sTPoFNWpV0HTCSXmdTaEhXkqiC6ThDkVBoCE0pYnQSwNR-hXDeFy51-xjCvSy6znLoy910ZwJvWdFxX67jNaHNhmFtLRj9NU1o3gI35uOdNRE-JIpEfE1bNogBet48pFt0BiyptdUE2Tt8rJs75NxtOLyLQyOMA1mqfumkAS2IWp9SALe86f_4P-cGnPf_h-b-bvoKVo_1efnjQ__wC7jEv69ENu8kGdGaTC_sS7uofs8F0stmE0TWm9B7o
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+trends+in+the+incidence+of+malignant+melanoma+1953%E2%80%932008%E2%80%94are+recent+generations+at+higher+or+lower+risk%3F&rft.jtitle=International+journal+of+cancer&rft.au=Erdmann%2C+Friederike&rft.au=Lortet%E2%80%90Tieulent%2C+Joannie&rft.au=Sch%C3%BCz%2C+Joachim&rft.au=Zeeb%2C+Hajo&rft.date=2013-01-15&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=132&rft.issue=2&rft.spage=385&rft.epage=400&rft_id=info:doi/10.1002%2Fijc.27616&rft.externalDBID=10.1002%252Fijc.27616&rft.externalDocID=IJC27616
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon